Free Trial

Immunic (IMUX) Short Interest Ratio & Short Volume

→ The ONE AI Stock to own now. (It’s not Nvidia.) (From Weiss Ratings) (Ad)
Free IMUX Stock Alerts
$1.25
0.00 (0.00%)
(As of 05/28/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends

Immunic Short Interest Data

Current Short Interest
2,820,000 shares
Previous Short Interest
2,820,000 shares
Change Vs. Previous Month
No Change
Dollar Volume Sold Short
$3.65 million
Short Interest Ratio
7.2 Days to Cover
Last Record Date
May 15, 2024
Outstanding Shares
90,080,000 shares
Percentage of Shares Shorted
3.13%
Today's Trading Volume
157,752 shares
Average Trading Volume
708,953 shares
Today's Volume Vs. Average
22%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Immunic ?

Sign up to receive the latest short interest report for Immunic and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

IMUX Short Interest Over Time

IMUX Days to Cover Over Time

IMUX Percentage of Float Shorted Over Time

Immunic Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/20242,820,000 shares $3.65 million No ChangeN/A7.2 $1.30
4/30/20242,820,000 shares $3.55 million -2.1%N/A5.7 $1.26
4/15/20242,880,000 shares $3.77 million -5.0%N/A4.9 $1.31
3/31/20243,030,000 shares $4.00 million +22.7%N/A3.1 $1.32
3/15/20242,470,000 shares $3.24 million +11.3%N/A2.5 $1.31
2/29/20242,220,000 shares $3.25 million -11.9%N/A2.4 $1.47
2/15/20242,520,000 shares $3.38 million -2.7%N/A2.9 $1.34
1/31/20242,590,000 shares $3.08 million -20.6%N/A3.3 $1.19
1/15/20243,260,000 shares $4.17 million +48.2%N/A4.2 $1.28
12/31/20232,200,000 shares $3.30 million -6.4%N/A1.9 $1.50
12/15/20232,350,000 shares $3.53 million -15.2%N/A2.9 $1.50
11/30/20232,770,000 shares $3.30 million -6.4%N/A3.5 $1.19
11/15/20232,960,000 shares $2.96 million -9.5%N/A3.8 $1.00
10/31/20233,270,000 shares $3.47 million -24.7%N/A4.1 $1.06
10/15/20234,340,000 shares $5.25 million +77.9%N/A5.4 $1.21
9/30/20232,440,000 shares $3.59 million -2.4%N/A3 $1.47
9/15/20232,500,000 shares $3.58 million +4.6%N/A2.7 $1.43
8/31/20232,390,000 shares $3.99 million +11.7%N/A2.5 $1.67
8/15/20232,140,000 shares $3.66 million +7.5%N/A2.1 $1.71
7/31/20231,990,000 shares $4.80 million -2.0%N/A1.9 $2.41
7/15/20232,030,000 shares $5.14 million -6.5%N/A1.9 $2.53
6/30/20232,170,000 shares $5.45 million +6.9%N/A2.1 $2.51
6/15/20232,030,000 shares $3.35 million -12.9%N/A1.9 $1.65
5/31/20232,330,000 shares $3.84 million -28.3%N/A2 $1.65
5/15/20233,250,000 shares $5.72 million -11.0%N/A2.6 $1.76
4/30/20233,650,000 shares $6.06 million -14.7%N/A2.8 $1.66
4/15/20234,280,000 shares $6.12 million +3.1%N/A3 $1.43
3/31/20234,150,000 shares $6.18 million -5.7%N/A2.7 $1.49
3/15/20234,400,000 shares $7.22 million -21.7%N/A4.4 $1.64
2/28/20235,620,000 shares $11.13 million +4.9%N/A5.6 $1.98
2/15/20235,360,000 shares $11.36 million -10.2%N/A5.6 $2.12
1/31/20235,970,000 shares $14.33 million -13.9%N/A5.5 $2.40
1/15/20236,930,000 shares $10.67 million -2.0%N/A3.6 $1.54
12/30/20227,070,000 shares $9.90 million -1.7%N/A1.8 $1.40
12/15/20227,190,000 shares $8.63 million +2.1%N/A1.9 $1.20
11/30/20227,040,000 shares $9.43 million +0.7%N/A1.9 $1.34
11/15/20226,990,000 shares $10.35 million -0.9%N/A1.9 $1.48
10/31/20227,050,000 shares $12.48 million +92.6%N/A2.1 $1.77
10/15/20223,660,000 shares $36.71 million +418.7%N/A1.2 $10.03
9/30/2022705,600 shares $2.23 million -20.9%N/A0.8 $3.16
Next President (Not Trump. Not Biden.) (Ad)

Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be Trump.

Click here to see why it will be ______ _________.
9/15/2022892,200 shares $3.57 million -3.2%N/A5.5 $4.00
8/31/2022921,200 shares $4.10 million -5.3%N/A4.4 $4.45
8/15/2022972,600 shares $5.34 million -7.4%N/A1.4 $5.49
7/31/20221,050,000 shares $3.72 million -9.5%N/A1.4 $3.54
7/15/20221,160,000 shares $4.55 million +3.6%N/A1.5 $3.92
6/30/20221,120,000 shares $3.89 million -41.1%N/A1.5 $3.47
6/15/20221,900,000 shares $6.46 million +22.6%N/A2.5 $3.40
5/31/20221,550,000 shares $9.61 million +25.0%N/A2.2 $6.20
5/15/20221,240,000 shares $7.25 million +8.8%N/A4.9 $5.85
4/30/20221,140,000 shares $7.72 million -20.3%N/A5 $6.77
4/15/20221,430,000 shares $14.89 million -5.3%7.0%5.6 $10.41
3/31/20221,510,000 shares $17.06 million -5.0%7.5%6.3 $11.30
3/15/20221,590,000 shares $16.46 million +17.8%7.9%5.6 $10.35
2/28/20221,350,000 shares $15.73 million -4.3%6.7%4.6 $11.65
2/15/20221,410,000 shares $18.65 million +13.7%7.5%5.4 $13.23
1/31/20221,240,000 shares $14.62 million +6.0%6.6%4.7 $11.79
1/15/20221,170,000 shares $13.86 million -14.0%N/A5.4 $11.85
12/31/20211,360,000 shares $13.02 million +29.5%7.2%6.4 $9.57
12/15/20211,050,000 shares $9.29 million +7.4%5.8%4.9 $8.85
11/30/2021978,000 shares $8.34 million +1.8%5.5%4.8 $8.53
11/15/2021961,100 shares $8.89 million +6.1%5.4%4.7 $9.25
10/29/2021905,500 shares $8.44 million +4.2%5.1%4.6 $9.32
10/15/2021868,700 shares $7.53 million -9.5%4.9%4 $8.67
9/30/2021959,700 shares $8.49 million +3.2%5.4%3.6 $8.85
9/15/2021930,400 shares $8.89 million -3.3%5.3%4.1 $9.55
8/31/2021962,400 shares $9.48 million -32.2%5.4%4.1 $9.85
8/13/20211,420,000 shares $13.43 million -13.4%8.0%6.3 $9.46
7/30/20211,640,000 shares $14.48 million -5.8%10.3%7.3 $8.83
7/15/20211,740,000 shares $16.25 million +12.3%10.9%8.5 $9.34
6/30/20211,550,000 shares $19.00 million +6.9%11.7%10.2 $12.26
6/15/20211,450,000 shares $19.00 million -2.0%11.0%10.9 $13.10
5/28/20211,480,000 shares $19.99 million -0.7%11.2%10.9 $13.51
5/14/20211,490,000 shares $19.52 million +0.7%N/A9.2 $13.10
4/30/20211,480,000 shares $22.82 million +2.1%N/A6.5 $15.42
4/15/20211,450,000 shares $21.05 million +2.1%N/A6.4 $14.52
3/31/20211,420,000 shares $20.80 million +52.4%N/A6.1 $14.65
3/15/2021931,800 shares $15.15 million -28.9%N/A3.5 $16.26
2/26/20211,310,000 shares $20.49 million +45.9%N/A5.1 $15.64
2/12/2021897,700 shares $18.38 million -4.8%N/A3.2 $20.47
1/29/2021942,700 shares $15.76 million +38.6%N/A4.1 $16.72
1/15/2021680,000 shares $12.25 million -27.0%N/A2.8 $18.02
12/31/2020931,700 shares $15.29 million +34.7%N/A3.6 $16.41
12/15/2020691,900 shares $12.97 million -34.1%N/A2.4 $18.75
11/30/20201,050,000 shares $18.43 million +33.7%N/A3 $17.55
11/15/2020785,500 shares $14.85 million +6.8%N/A1.7 $18.90
10/30/2020735,200 shares $12.58 million +4.8%N/A1.5 $17.11
10/15/2020701,800 shares $13.27 million -33.8%N/A1.1 $18.91
9/30/20201,060,000 shares $19.68 million +38.0%N/A1.7 $18.57
9/15/2020768,100 shares $13.76 million +64.1%N/A1.2 $17.92
8/31/2020468,200 shares $7.51 million +79.1%N/A0.8 $16.05
Next President (Not Trump. Not Biden.) (Ad)

Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be Trump.

Click here to see why it will be ______ _________.
8/14/2020261,400 shares $5.18 million +84.9%N/A0.5 $19.83
7/31/2020141,400 shares $2.43 million -3.4%N/A0.3 $17.20
7/15/2020146,400 shares $1.77 million +10.2%1.8%0.4 $12.11
6/30/2020132,800 shares $1.66 million +129.8%1.9%0.4 $12.49
6/15/202057,800 shares $643,314.00 -11.5%0.9%0.2 $11.13
5/29/202065,300 shares $707,852.00 -55.3%1.1%0.3 $10.84
5/15/2020146,100 shares $1.44 million +139.9%3.2%0.9 $9.85
4/30/202060,900 shares $524,958.00 +25.6%1.4%0.6 $8.62
4/15/202048,500 shares $363,265.00 -2.8%1.3%0.7 $7.49
3/31/202049,900 shares $459,080.00 +25.7%1.3%2.2 $9.20
3/13/202039,700 shares $258,050.00 -2.9%1.3%4.6 $6.50
2/28/202040,900 shares $215,134.00 +7.9%1.3%1.4 $5.26
2/14/202037,900 shares $308,127.00 +4.7%1.2%1.2 $8.13
1/31/202036,200 shares $285,256.00 -32.2%1.2%1.1 $7.88
1/15/202053,400 shares $465,648.00 -14.6%1.7%1.8 $8.72
12/31/201962,500 shares $513,750.00 +30.2%2.0%2.2 $8.22

IMUX Short Interest - Frequently Asked Questions

What is Immunic's current short interest?

Short interest is the volume of Immunic shares that have been sold short but have not yet been closed out or covered. As of May 15th, investors have sold 2,820,000 shares of IMUX short. Learn More on Immunic's current short interest.

What is a good short interest ratio for Immunic?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IMUX shares currently have a short interest ratio of 7.0. Learn More on Immunic's short interest ratio.

How does Immunic's short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Immunic: Adagene Inc. (0.03%), DiaMedica Therapeutics Inc. (0.34%), Cellectar Biosciences, Inc. (6.54%), Nuvectis Pharma, Inc. (14.41%), Clearside Biomedical, Inc. (0.46%), Abeona Therapeutics Inc (7.76%), Vistagen Therapeutics, Inc. (4.36%), FibroGen, Inc. (7.42%), PMV Pharmaceuticals, Inc. (6.27%), CervoMed Inc. (2.36%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks.

What does it mean to sell short Immunic stock?

Short selling IMUX is an investing strategy that aims to generate trading profit from Immunic as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Immunic?

A short squeeze for Immunic occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of IMUX, which in turn drives the price of the stock up even further.

How often is Immunic's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IMUX, twice per month. The most recent reporting period available is May, 15 2024.



More Short Interest Resources from MarketBeat

Related Companies:
Short Interest Tools:
This page (NASDAQ:IMUX) was last updated on 5/29/2024 by MarketBeat.com Staff

From Our Partners
The #1 Crypto That You Don’t Own… Yet
Crypto 101 Media
You won't believe what Citigroup just did to it's depositors
American Alternative
4 Cryptos BETTER than Bitcoin
True Market Insiders
He Is Giving Away Bitcoin
Crypto Swap Profits
Write this ticker symbol down…
StocksToTrade
Bill Clinton Backing Biden Replacement???
The Freeport Society
Must-See: Elon’s New Invention is Absolutely Insane
InvestorPlace
Nvidia is Pivoting to Solve Big Tech’s $1 Trillion Problem
Weiss Ratings